![]() | Up a level |
Nomikos, N., Naoum, P., Athanasakis, Kostas and Kyriopoulos, I ORCID: 0000-0002-3932-8228
(2024)
Cost-effectiveness analysis of filgotinib as a first-line treatment for biologic-naive patients with Ulcerative Colitis in Greece.
Value in Health, 27 (12, Supplement).
S80 - S80.
ISSN 1098-3015
Nomikos, N., Naoum, P., Athanasakis, K. and Kyriopoulos, I ORCID: 0000-0002-3932-8228
(2024)
Cost-effectiveness analysis of filgotinib versus tofacitinib as first-line treatments for rheumatoid arthritis in Greece.
Value in Health, 27 (12, Supplement).
S80 - S80.
ISSN 1098-3015
Nomikos, N., Naoum, P., Athanasakis, K. and Kyriopoulos, I ORCID: 0000-0002-3932-8228
(2024)
EE477 A budget impact analysis of introducing filgotinib for the treatment of rheumatoid arthritis in Greece.
Value in Health, 27 (12 Supplement).
S149.
ISSN 1098-3015
Nomikos, N., Naoum, P., Athanasakis, K. and Kyriopoulos, I ORCID: 0000-0002-3932-8228
(2024)
EE478 A budget impact analysis of introducing filgotinib as a first-line treatment for moderate to severe ulcerative colitis in Greece.
Value in Health, 27 (12 Supplement).
S149.
ISSN 1098-3015